Gene expression changes in a transgenic mouse model overexpressing human wildtype and mutant torsinA

• Published in: Proteomics. Clinical applications 2008-05, Vol.2 (5), p.720-736
• Main Authors: Grundmann, Kathrin, Hübener, Jeannette, Häbig, Karina, Reischmann, Bettina, Poths, Sven, Hauser, Till-Karsten, Magg, Janine, Riess, Olaf, Bonin, Michael, Nguyen, Huu Phuc
• Format: Article
• Language: English
• Subjects: DYT1 dystonia; TorsinA; Transcriptome; Transgenic mouse model
• ISSN: 1862-8346; 1862-8354
• DOI: 10.1002/prca.200780053

Primary torsion dystonia is an autosomal‐dominantly inherited, neurodevelopmental movement disorder caused by a GAG deletion (ΔGAG) in the DYT1 gene, encoding torsinA. This mutation is responsible for approximately 70% of cases of early‐onset primary torsion dystonia. The function of wildtype torsinA is still unknown, and it is unsolved how the deletion in the DYT1 gene contributes to the development of the disease. To better understand the molecular processes involved in torsinA pathology, we used genome‐wide oligonucleotide microarrays to characterize gene expression patterns in the striatum of mouse models overexpressing the human wildtype and mutant torsinA. By this approach we were able to detect gene expression changes that seem to be specific for torsinA pathology. We found an impact of torsinA, independent from genotype, on vesicle trafficking, exocytosis, and neurotransmitter release in our mouse model. In addition, we were able to identify several new pathways and processes involved in the development of the nervous system that are affected by wildtype and mutant torsinA. Furthermore, we have striking evidence from our gene expression data that glutamate receptor mediated synaptic plasticity in the striatum is the affected underlying cellular process for impaired motor learning in human ΔGAG torsinA transgenic mice.